Serine racemase binds to PICK1: potential relevance to schizophrenia
Open Access
- 29 November 2005
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 11 (2) , 150-157
- https://doi.org/10.1038/sj.mp.4001776
Abstract
Accumulating evidence from both genetic and clinico-pharmacological studies suggests that D-serine, an endogenous coagonist to the NMDA subtype glutamate receptor, may be implicated in schizophrenia (SZ). Although an association of genes for D-serine degradation, such as D-amino acid oxidase and G72, has been reported, a role for D-serine in SZ has been unclear. In this study, we identify and characterize protein interacting with C-kinase (PICK1) as a protein interactor of the D-serine synthesizing enzyme, serine racemase (SR). The binding of endogenous PICK1 and SR requires the PDZ domain of PICK1. The gene coding for PICK1 is located at chromosome 22q13, a region frequently linked to SZ. In a case–control association study using well-characterized Japanese subjects, we observe an association of the PICK1 gene with SZ, which is more prominent in disorganized SZ. Our findings implicating PICK1 as a susceptibility gene for SZ are consistent with a role for D-serine in the disease.Keywords
This publication has 65 references indexed in Scilit:
- Assessment of two flexible and compatible SNP genotyping platforms: TaqMan® SNP Genotyping Assays and the SNPlex™ Genotyping SystemMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophreniaNature Genetics, 2004
- Association of G72/G30 with schizophrenia in the Chinese populationBiochemical and Biophysical Research Communications, 2004
- Neuron–glia interactions clarify genetic–environmental links in mental illnessTrends in Neurosciences, 2004
- Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorderMolecular Psychiatry, 2004
- Glutamatergic Mechanisms in SchizophreniaAnnual Review of Pharmacology and Toxicology, 2002
- The Emerging Role of Glutamate in the Pathophysiology and Treatment of SchizophreniaAmerican Journal of Psychiatry, 2001
- The protein kinase Cα binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunitsNeuropharmacology, 1999
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976